10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America
artículo científico publicado en 2013
1454Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes.
artículo científico publicado en 2014
1534. Polymyxin Antimicrobial Susceptibility (AST) Testing and Breakpoints for P. aeruginosa, A. baumannii, and Enterobacteriaceae: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)
1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates
artículo científico publicado en 2019
1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States
247Antimicrobial Activity of Ceftolozane/Tazobactam Tested against Gram-negative Bacterial Isolates from Hospitalized Patients with Pneumonia in United States Hospitals (2013).
artículo científico publicado en 2014
250Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants.
artículo científico publicado en 2014
2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data
257In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains.
artículo científico publicado en 2014
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
artículo científico publicado en 1984
410Tracking Linezolid Antimicrobial Activity and Resistance in North America: Results from LEADER 2013 Program.
artículo científico publicado en 2014
470Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013).
artículo científico publicado en 2014
475Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013).
artículo científico publicado en 2014
729Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013).
artículo científico publicado en 2014
811Antimicrobial activity of ceftaroline tested against respiratory tract infection (RTI) pathogens isolated from USA medical centers in 2013.
artículo científico publicado en 2014
A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States
artículo científico publicado en 1997
A Cluster of Serious Escherichia coli Infections in a Neonatal Intensive-Care Unit
scholarly article by Daniel J. Diekema et al published November 1997 in Infection Control and Hospital Epidemiology
A cluster of serious Escherichia coli infections in a neonatal intensive-care unit
artículo científico publicado en 1997
A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India
artículo científico publicado en 2002
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
artículo científico publicado en 2008
A multicenter evaluation of linezolid antimicrobial activity in North America
artículo científico publicado en 2002
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
artículo científico publicado en 2000
A pragmatic approach to identify extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan: in vitro activity of newer and established antimicrobial agents
artículo científico publicado en 2004
A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide
⬇️
artículo científico publicado el 1 de agosto de 1997
A simple stacked disc technique for testing bacterial susceptibility to antimicrobial agents in combination with sulbactam
artículo científico publicado en 1989
A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studies
scientific article published on 01 January 1982
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
artículo científico publicado en 2012
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains
artículo científico publicado en 2002
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000)
⬇️
artículo científico publicado el 22 de enero de 2004
Ability of the modified Vitek card to detect coagulase-negative staphylococcal with mecA and Oxacillin-resistant phenotypes
artículo científico publicado en 1999
Accuracy of broth microdilution and E test methods for detecting chloramphenicol acetyl transferase mediated resistance in Streptococcus pneumoniae: Geographic variations in the prevalence of resistance in The SENTRY Antimicrobial Surveillance Progr
artículo científico publicado en 2001
Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System.
artículo científico publicado en 1999
Accuracy of the Thermo Fisher Scientific (Sensititre™) dry-form broth microdilution MIC product when testing ceftaroline
artículo científico publicado en 2014
Accuracy of the Vitek system for antimicrobial susceptibility testing Enterobacteriaceae bloodstream infection isolates: use of “direct” inoculation from Bactec 9240 blood culture bottles
⬇️
artículo científico publicado el 1 de junio de 1997
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents
artículo científico publicado en 2006
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System
scientific article published on 01 July 1996
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods
artículo científico publicado en 2011
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
artículo científico publicado en 2016
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi
artículo científico publicado en 2003
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates
artículo científico publicado en 2009
Activities of doripenem (S-4661) against drug-resistant clinical pathogens
artículo científico publicado en 2004
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program
artículo científico publicado en 2012
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
artículo científico publicado en 2000
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci
artículo científico publicado en 2001
Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
artículo científico publicado en 2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States
artículo científico publicado en 2001
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis
artículo científico publicado en 2006
Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains
artículo científico publicado en 2015
Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.
artículo científico publicado en 2016
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial
artículo científico publicado en 2012
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia
⬇️
artículo científico publicado el 4 de febrero de 2012
Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains
⬇️
artículo científico publicado el 21 de julio de 2012
Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp
⬇️
artículo científico publicado el 1 de septiembre de 1998
Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
artículo científico publicado en 2012
Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals (2016-2017): Effect of Different Breakpoint Criteria on in the Susceptibility Rates among Aminoglycosides
artículo científico publicado en 2020
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)
artículo científico publicado en 1998
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates
scientific article published on 10 June 2016
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae
artículo científico publicado en 1997
Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan
artículo científico publicado en 2005
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime
scientific article published on 01 January 1989
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States
artículo científico publicado en 2010
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
artículo científico publicado en 2015
Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel
artículo científico publicado en 2013
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types
artículo científico publicado en 2012
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States
artículo científico publicado en 2014
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
artículo científico publicado en 2013
Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).
artículo científico publicado en 2009
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States
artículo científico publicado en 2007
Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).
artículo científico publicado en 2009
Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers
artículo científico publicado en 2008
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections
artículo científico publicado en 2014
Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains
artículo científico publicado en 2005
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values
scientific article published on 03 April 2007
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.
artículo científico publicado en 1999
Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
artículo científico publicado en 2006
Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes
artículo científico publicado en 2006
Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2007
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the
scientific article published on 01 February 2000
Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).
artículo científico publicado en 2007
Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2004
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
artículo científico publicado en 2014
Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide
artículo científico publicado en 2014
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci
artículo científico publicado en 2006
Activity of six contemporary antibacterial agents against 96 isolates from purulent meningitis: the contribution of desacetylcefotaxime to antimicrobial potency
artículo científico publicado en 1987
Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations
artículo científico publicado en 2017
Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
artículo científico publicado en 2010
Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centres
artículo científico publicado en 1986
Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species
artículo científico publicado en 1996
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
artículo científico publicado en 2005
Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates
artículo científico publicado en 1995
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000.
artículo científico publicado en 2002
Ampicillin-resistant Haemophilus paraphrophilus laryngo-epiglottitis
artículo científico publicado en 1976
An in vitro evaluation of HRE 664, a novel penem antibiotic.
artículo científico publicado en 1988
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.
artículo científico publicado en 2013
Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013).
artículo científico publicado en 2015
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
artículo científico publicado en 2005
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin
artículo científico publicado en 2015
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?
artículo científico publicado en 2003
Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation
⬇️
artículo científico publicado el 1 de septiembre de 1997
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods
artículo científico publicado en 2000
Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines
artículo científico publicado en 1999
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid
⬇️
artículo científico publicado el 1 de mayo de 1984
Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
artículo científico publicado en 2001
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests
artículo científico publicado en 1981
Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests
artículo científico publicado en 1989
Antibiotic resistance. Epidemiology and therapeutics
artículo científico publicado el 1 de febrero de 1992
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P
artículo científico publicado en 2002
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi
scientific article published on 01 December 1998
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
artículo científico publicado en 1997
Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
artículo científico publicado en 2015
Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria
artículo científico publicado en 1995
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
artículo científico publicado en 2016
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014.
artículo científico publicado en 2016
Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States
⬇️
artículo científico publicado el 1 de marzo de 1998
Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes
⬇️
artículo científico publicado el 14 de febrero de 2011
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers
artículo científico publicado en 2016
Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009)
⬇️
artículo científico publicado el 1 de agosto de 2011
Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy
⬇️
artículo científico publicado el 1 de septiembre de 1982
Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
artículo científico publicado en 2017
Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
⬇️
artículo científico publicado el 1 de julio de 1998
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum.
artículo científico publicado en 1995
Antimicrobial Resistance Surveillance and New Drug Development
article
Antimicrobial Susceptibility Tests with Cefotaxime and Correlation with Clinical Bacteriologic Response
⬇️
artículo científico publicado el 1 de septiembre de 1982
Antimicrobial Susceptibility of Complex and Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)
Antimicrobial Susceptibility of Klebsiella pneumoniae Producing Extended-Spectrum beta-lactamase (ESBL) Isolated in Hospitals in Brazil
scientific article published on 01 August 1997
Antimicrobial Susceptibility of from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
article
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus
artículo científico publicado en 2008
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
artículo científico publicado en 2009
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.
artículo científico publicado en 2004
Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinol
artículo científico publicado en 2009
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2007
Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe
artículo científico publicado en 2003
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)
artículo científico publicado en 1988
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species
artículo científico publicado en 2000
Antimicrobial activity and other in vitro properties of cefoperazone A, the principal metabolite of cefoperazone sodium
artículo científico publicado en 1983
Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations
artículo científico publicado en 1987
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains
artículo científico publicado en 2005
Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group.
artículo científico publicado en 1999
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates
artículo científico publicado en 1980
Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
artículo científico publicado en 2010
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative
artículo científico publicado en 1993
Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates
artículo científico publicado en 1996
Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).
artículo científico publicado en 1999
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
artículo científico publicado en 1991
Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis
⬇️
artículo científico publicado el 1 de febrero de 1995
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-Enteric Gram-negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes
⬇️
artículo científico publicado el 1 de noviembre de 1997
Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods
⬇️
artículo científico publicado el 1 de noviembre de 2001
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates
artículo científico publicado en 2008
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems
artículo científico publicado en 1991
Antimicrobial activity of FK-037 against class I beta-lactamase producing species resistant to ceftazidime: a multi-laboratory clinical isolate sample.
artículo científico publicado en 1993
Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime
artículo científico publicado en 1994
Antimicrobial activity of HR810 against 419 strict anaerobic bacteria
artículo científico publicado en 1985
Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae
⬇️
artículo científico publicado el 1 de agosto de 2003
Antimicrobial activity of LB20304, a fluoronaphthyridone, tested against anaerobic bacteria
⬇️
artículo científico publicado el 1 de octubre de 1997
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
artículo científico publicado en 2005
Antimicrobial activity of MDL 19,592: an oral cephalosporin.
artículo científico publicado en 1988
Antimicrobial activity of RU-66647, a new ketolide
artículo científico publicado en 1997
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
artículo científico publicado en 1986
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates
artículo científico publicado en 1987
Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime
artículo científico publicado en 1989
Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.
artículo científico publicado en 1999
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
artículo científico publicado en 1994
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
artículo científico publicado en 2006
Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).
artículo científico publicado en 2000
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins
artículo científico publicado en 1982
Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
artículo científico publicado en 2002
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States
artículo científico publicado en 2008
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study
artículo científico publicado en 1994
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
artículo científico publicado en 2006
Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods
artículo científico publicado en 1986
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens)
⬇️
artículo científico publicado el 1 de mayo de 1995
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
artículo científico publicado en 1991
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
artículo científico publicado en 2013
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals
artículo científico publicado en 2016
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).
artículo científico publicado en 2014
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.
artículo científico publicado en 2015
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers
artículo científico publicado en 2014
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
artículo científico publicado en 2013
Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011.
artículo científico publicado en 2013
Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.
artículo científico publicado en 2013
Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
artículo científico publicado en 2016
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
artículo científico publicado en 2008
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012).
artículo científico publicado en 2013
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
scientific article published on 10 June 2014
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum
artículo científico publicado en 1987
Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
artículo científico publicado en 1987
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
artículo científico publicado en 2005
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide
artículo científico publicado en 2004
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients
artículo científico publicado en 2008
Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus
scientific article published on 01 June 2012
Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).
artículo científico publicado en 2013
Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
artículo científico publicado en 2010
Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
artículo científico publicado en 2005
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
artículo científico publicado en 2005
Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
artículo científico publicado en 2009
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Su
artículo científico publicado en 1999
Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers
artículo científico publicado en 1999
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America
artículo científico publicado en 1998
Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains
artículo científico publicado en 1998
Antimicrobial activity of imipenem and SCH34343 against Legionella species
artículo científico publicado en 1987
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil
⬇️
artículo científico publicado el 7 de marzo de 2003
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections
artículo científico publicado en 2008
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections
artículo científico publicado en 2008
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea
artículo científico publicado en 2009
Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.
artículo científico publicado en 2015
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections
artículo científico publicado en 2012
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
artículo científico publicado en 1993
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
⬇️
artículo científico publicado el 27 de enero de 2012
Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
artículo científico publicado en 2012
Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010.
artículo científico publicado en 2013
Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections
artículo científico publicado en 2004
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
artículo científico publicado en 2007
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).
artículo científico publicado en 2017
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit
artículo científico publicado en 2005
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia
artículo científico publicado en 2005
Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae interpretive criteria and comparisons with Etest results
⬇️
artículo científico publicado el 1 de agosto de 1997
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
artículo científico publicado en 1983
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin
artículo científico publicado en 1988
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
artículo científico publicado en 2010
Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing
artículo científico publicado en 1997
Antimicrobial interactions (Synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against Gram-positive isolates from Germany and the United States
⬇️
artículo científico publicado el 1 de octubre de 1997
Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia
scientific article published on 01 October 1998
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).
artículo científico publicado en 2012
Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals
artículo científico publicado en 2009
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program
scientific article published on 26 March 2007
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America
artículo científico publicado en 2001
Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003).
artículo científico publicado en 2004
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.
artículo científico publicado en 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)
⬇️
artículo científico publicado el 1 de diciembre de 2001
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates
artículo científico publicado en 2004
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol
artículo científico publicado en 2005
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America
artículo científico publicado en 2003
Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group
artículo científico publicado en 1990
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections
artículo científico publicado en 2010
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
artículo científico publicado en 2004
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012
artículo científico publicado en 2014
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
artículo científico publicado en 2013
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
artículo científico publicado en 2009
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
scientific article published on 24 May 2007
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres
artículo científico publicado en 2010
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2004
Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997).
artículo científico publicado en 1999
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005–2010)
⬇️
artículo científico publicado el 4 de mayo de 2011
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)
scientific article published on 01 September 2006
Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000.
artículo científico publicado en 2002
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study
artículo científico publicado en 2001
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli
artículo científico publicado en 2005
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
artículo científico publicado en 2006
Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae
artículo científico publicado en 2010
Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).
artículo científico publicado en 2002
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
artículo científico publicado en 2016
Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002).
artículo científico publicado en 2005
Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program--North America, 2001.
artículo científico publicado en 2003
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
artículo científico publicado en 2008
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae
artículo científico publicado en 1988
Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2001
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
artículo científico publicado en 2004
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
artículo científico publicado en 2009
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum
artículo científico publicado en 1986
Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
artículo científico publicado en 1985
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
article
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi
artículo científico publicado en 2005
Application of the Etest to antimicrobial susceptibility testing of Legionella spp
scientific article published on 01 July 1994
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia
artículo científico publicado en 2015
Are Enterococcus faecalis strains with vat(E) in poultry a reservoir for human streptogramin resistance? vat(E) occurrence in human enterococcal bloodstream infections in North America (SENTRY Antimicrobial Surveillance Program, 2002).
artículo científico publicado en 2004
Assessment of BMS284756 MIC and 5-μg disk diffusion quality control studies tested against seven American type culture collection strains
⬇️
artículo científico publicado el 1 de diciembre de 2001
Assessment of Ceftazidime-Avibactam 30/20 μg Disk Content Versus MIC Results When Tested against Enterobacteriaceae and Pseudomonas aeruginosa
artículo científico publicado en 2018
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy
⬇️
artículo científico publicado el 14 de septiembre de 2010
Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
artículo científico publicado en 2006
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
artículo científico publicado en 2004
Automation of polymerase chain reaction tests. Reduction of human errors leading to contamination
artículo científico publicado en 1995
Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value
artículo científico publicado en 2013
Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States
⬇️
artículo científico publicado el 1 de diciembre de 1997
Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks
artículo científico publicado en 1982
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
artículo científico publicado en 1985
BAY 12-8039, a novel fluoroquinolone. Activity against important respiratory tract pathogens
artículo científico publicado en 1998
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
artículo científico publicado en 1977
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
artículo científico publicado en 2002
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates
artículo científico publicado en 1988
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents
scientific article published on 01 May 1985
Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam
⬇️
artículo científico publicado el 18 de enero de 2013
Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
⬇️
artículo científico publicado el 1 de julio de 1998
Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 1999
Bacterial Resistance: A Worldwide Problem
⬇️
artículo científico publicado el 1 de junio de 1998
Bacterial antibiotic resistance before and after clinical application in the United States.
artículo científico publicado en 1987
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou
artículo científico publicado en 1999
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci
⬇️
artículo científico publicado el 1 de noviembre de 2003
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
artículo científico publicado en 2004
Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae
scientific article published on 01 December 2006
Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae
⬇️
artículo científico publicado el 1 de mayo de 1995
Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae
artículo científico publicado en 2004
Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method
artículo científico publicado en 2014
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
artículo científico publicado en 1987
Binaphthyl-based dicationic peptoids with therapeutic potential.
artículo científico publicado en 2010
Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa.
artículo científico publicado en 2003
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
artículo científico publicado en 2000
Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents
artículo científico publicado en 2005
CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance
artículo científico publicado en 2003
CEM-101 activity against Gram-positive organisms
artículo científico publicado en 2010
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
artículo científico publicado en 2010
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria
artículo científico publicado en 1987
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
artículo científico publicado en 2001
Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group
scientific article published on 01 January 1995
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
artículo científico publicado en 2011
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
artículo científico publicado en 2010
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillan
artículo científico publicado en 2012
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
artículo científico publicado en 2008
Carbapenem susceptibility discords among Acinetobacter isolates
artículo científico publicado en 2006
Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme
artículo científico publicado en 2001
Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene
artículo científico publicado en 2007
Case report of Aurantimonas altamirensis bloodstream infection
artículo científico publicado en 2008
Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae
artículo científico publicado en 2013
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
artículo científico publicado en 1992
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections
artículo científico publicado en 2005
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections
artículo científico publicado en 2007
Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods
artículo científico publicado en 2000
Cefditoren in vitro activity and spectrum: a review of international studies using reference methods
⬇️
artículo científico publicado el 1 de septiembre de 2001
Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan
artículo científico publicado en 2002
Cefixime disk susceptibility test criteria
artículo científico publicado en 1986
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
artículo científico publicado en 1987
Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria
⬇️
artículo científico publicado el 1 de diciembre de 1981
Cefoperazone and cefoperazone-sulbactam susceptibility tests with anaerobic bacteria by the thioglycolate disk elution method
artículo científico publicado en 1985
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits
⬇️
artículo científico publicado el 1 de mayo de 1982
Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test
scientific article published on 01 January 1980
Cefoperazone: spectrum of antibacterial activity and disc diffusion testing
scientific article published on 01 January 1981
Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity
⬇️
artículo científico publicado el 1 de septiembre de 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing
artículo científico publicado en 1982
Cefotiam susceptibility testing criteria
artículo científico publicado en 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stability
artículo científico publicado en 1985
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media
artículo científico publicado en 1986
Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
artículo científico publicado en 1994
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test
⬇️
artículo científico publicado el 1 de octubre de 1981
Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate
artículo científico publicado en 2016
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
artículo científico publicado en 2017
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
artículo científico publicado en 2014
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
artículo científico publicado en 2015
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
artículo científico publicado en 2013
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study
artículo científico publicado en 2010
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
artículo científico publicado en 2014
Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011).
artículo científico publicado en 2014
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011).
artículo científico publicado en 2013
Ceftaroline activity tested against viridans group streptococci from US hospitals
artículo científico publicado en 2015
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program
scientific article published on 01 September 2012
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests
artículo científico publicado en 1981
Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014.
artículo científico publicado en 2016
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
artículo científico publicado en 2015
Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains
artículo científico publicado en 2015
Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).
artículo científico publicado en 2015
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).
artículo científico publicado en 2014
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).
artículo científico publicado en 2014
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia
artículo científico publicado en 2015
Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines
artículo científico publicado en 1988
Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
artículo científico publicado en 1987
Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae
artículo científico publicado en 1993
Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, -lactamase stability, and inhibition
⬇️
artículo científico publicado el 1 de noviembre de 1982
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010.
artículo científico publicado en 2014
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)
artículo científico publicado en 2014
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
artículo científico publicado en 2014
Ceftriaxone: A summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-μg disks
⬇️
artículo científico publicado el 1 de diciembre de 1983
Cefuroxime, an in vitro Comparison with Six Other Cephalosporins
⬇️
artículo científico publicado el 1 de enero de 1977
Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines
scientific article published on 01 August 1983
Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates
artículo científico publicado en 2016
Changing Antimicrobial Susceptibility Patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004)
article
Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.
artículo científico publicado en 1999
Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.
artículo científico publicado en 2001
Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007).
artículo científico publicado en 2008
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital
artículo científico publicado en 2007
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid
artículo científico publicado en 2009
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY An
artículo científico publicado en 2006
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans
artículo científico publicado en 2003
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline
artículo científico publicado en 2012
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
artículo científico publicado en 2012
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).
artículo científico publicado en 2008
Chloramphenicol susceptibility testing of Haemophilus influenzae
artículo científico publicado en 1987
Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?
artículo científico publicado en 2002
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin
artículo científico publicado en 1992
Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae
scientific article published on 01 August 1996
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole
artículo científico publicado en 2004
Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.
artículo científico publicado en 2001
Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California
artículo científico publicado en 2009
Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy
scientific article published on 27 April 2009
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
artículo científico publicado en 2006
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2008
Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility
artículo científico publicado en 1982
Collaborative evaluation of the microbial profile system for quantitative antimicrobial susceptibility testing
artículo científico publicado en 1983
Colony morphology of Candida spp. as a guide to species identification
artículo científico publicado en 1999
Combinations of Orally Administered β-Lactams to Maximize Spectrum and Activity against Drug-resistant Respiratory Tract Pathogens: I. Synergy Studies of Amoxicillin and Cefixime with Streptococcus pneumoniae
⬇️
artículo científico publicado el 1 de junio de 1998
Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.
artículo científico publicado en 2010
Commentary: revised susceptibility breakpoints: fear, loathing and good science
artículo científico publicado en 2013
Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase
scientific article published on 01 September 2004
Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinolone
artículo científico publicado en 2003
Comparative Antimicrobial Activity and Kill-Curve Investigations of Novel Ketolide Antimicrobial Agents (HMR 3004 and HMR 3647) Tested against Haemophilus influenzae and Moraxella catarrhalis Strains
⬇️
artículo científico publicado el 1 de junio de 1998
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype
scientific article published on 01 December 2006
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North Ame
⬇️
artículo científico publicado el 1 de octubre de 2003
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms
artículo científico publicado en 2005
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999–2001)
⬇️
artículo científico publicado el 1 de abril de 2003
Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance Program
⬇️
artículo científico publicado el 14 de abril de 2011
Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance
artículo científico publicado en 2008
Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
artículo científico publicado en 2005
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests
artículo científico publicado en 1996
Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae
artículo científico publicado en 2001
Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates
artículo científico publicado en 1987
Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates
artículo científico publicado en 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group
artículo científico publicado en 1999
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years
⬇️
artículo científico publicado el 1 de marzo de 1995
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season
artículo científico publicado en 1998
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance
artículo científico publicado en 2005
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).
artículo científico publicado en 2005
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development
artículo científico publicado en 2001
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons
artículo científico publicado en 2002
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli
artículo científico publicado en 2002
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin
⬇️
artículo científico publicado el 1 de noviembre de 1997
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administratio
artículo científico publicado en 1996
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study
⬇️
artículo científico publicado el 1 de abril de 2011
Comparative evaluation of etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents. An investigation using U.S. Food and Drug Administration regulatory criteria
scientific article published on 01 March 1997
Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.
artículo científico publicado en 1999
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA
⬇️
artículo científico publicado el 1 de noviembre de 1997
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
artículo científico publicado en 1999
Comparative potencies of contemporary generic vancomycin lot: in vitro assay results from nine products and a reference reagent-grade sample
artículo científico publicado en 2013
Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor
artículo científico publicado en 2003
Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance
artículo científico publicado en 2009
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation
⬇️
artículo científico publicado el 18 de septiembre de 2010
Comparison of BD Max StaphSR and BD Max MRSAXT for Screening of Staphylococcus aureus Clinical Isolates Collected from Hospitals in the United States
artículo científico publicado en 2016
Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
artículo científico publicado en 2014
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
artículo científico publicado en 2010
Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2003
Comparison of amino acid decarboxylase and dihydrolase results by Moeller, rapid, and replicator plate methods
artículo científico publicado en 1976
Comparison of cefadroxil and cephalothin disk susceptibility test results
scientific article published on July 1989
Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables
artículo científico publicado en 2006
Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms
artículo científico publicado en 2006
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species
artículo científico publicado en 1994
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin
artículo científico publicado en 1980
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection
scientific article published on 01 May 2000
Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus
artículo científico publicado en 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphyloc
artículo científico publicado en 2001
Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998
artículo científico publicado en 2000
Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
artículo científico publicado en 1983
Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae
artículo científico publicado en 2007
Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
artículo científico publicado en 2001
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
artículo científico publicado en 2006
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study
artículo científico publicado en 2004
Complete Sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States
artículo científico publicado en 2008
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
artículo científico publicado en 2007
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics
artículo científico publicado en 1980
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009)
⬇️
artículo científico publicado el 1 de noviembre de 2010
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
artículo científico publicado en 2005
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)
scientific article published on 13 February 2013
Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan
artículo científico publicado en 2003
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
artículo científico publicado en 2011
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
artículo científico publicado en 2006
Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia
artículo científico publicado en 2006
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines
artículo científico publicado en 2001
Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
artículo científico publicado en 2006
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups
artículo científico publicado en 2013
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)
⬇️
artículo científico publicado el 1 de noviembre de 2003
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001).
artículo científico publicado en 2003
Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli
⬇️
artículo científico publicado el 1 de noviembre de 2003
Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria
⬇️
artículo científico publicado el 1 de abril de 2013
Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004)
artículo científico publicado en 2006
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States
artículo científico publicado en 2003
Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens
⬇️
artículo científico publicado el 13 de marzo de 2013
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination
artículo científico publicado en 1988
Critical appraisal of E test for the detection of fluoroquinolone resistance
scientific article published on 01 July 1996
Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods
⬇️
artículo científico publicado el 1 de mayo de 1997
Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin.
scientific article published on August 1987
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations
artículo científico publicado en 1984
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
artículo científico publicado en 1995
Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria
artículo científico publicado en 1995
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program
⬇️
artículo científico publicado el 1 de julio de 1998
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
artículo científico publicado en 2016
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
artículo científico publicado en 2005
Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groups
artículo científico publicado en 2013
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms
artículo científico publicado en 2004
Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012).
artículo científico publicado en 2014
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates
artículo científico publicado en 2009
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
artículo científico publicado en 2007
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin
artículo científico publicado en 2006
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.
artículo científico publicado en 2005
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis
artículo científico publicado en 2005
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998–2009)
⬇️
artículo científico publicado el 1 de noviembre de 2010
Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents
artículo científico publicado en 2014
Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins
scholarly article by Michael A. Pfaller et al published 5 April 2011 in Current fungal infection reports
Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone
scientific article published on 26 July 2018
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside
artículo científico publicado en 2006
Desacetylcefotaxime--another broad spectrum cephalosporin?
artículo científico publicado en 1989
Detection of NDM-1-producing Enterobacteriaceae in Romania: report of the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2013
Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2015
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.
artículo científico publicado en 1996
Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.
artículo científico publicado en 2016
Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America
artículo científico publicado en 2008
Detection of staphylococcal resistance to penicillinase-resistant penicillins. A comparison of two widely used disk diffusion methods.
artículo científico publicado en 1989
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection
artículo científico publicado en 2010
Determination of Disk Diffusion and MIC Quality Control Guidelines for High Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin
artículo científico publicado en 2017
Determination of Disk Diffusion and MIC Quality Control Guidelines for JNJ-Q2, a Novel Quinolone
⬇️
artículo científico publicado el 8 de junio de 2011
Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae
artículo científico publicado en 2015
Determination of MIC quality control ranges for ABT-733, a novel ketolide antimicrobial agent. Quality Control Study Group
artículo científico publicado en 2000
Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent
artículo científico publicado en 2014
Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial
artículo científico publicado en 2013
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone
artículo científico publicado en 2003
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor
artículo científico publicado en 2011
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
artículo científico publicado en 2004
Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms
artículo científico publicado en 1999
Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report
artículo científico publicado en 2009
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.
artículo científico publicado en 2004
Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.
artículo científico publicado en 2007
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy
artículo científico publicado en 2006
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group
artículo científico publicado en 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone
artículo científico publicado en 1999
Development, characterization, and initial evaluations of S1. A new chromogenic cephalosporin for beta-lactamase detection
artículo científico publicado en 1995
Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide
artículo científico publicado en 2015
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia
artículo científico publicado en 2017
Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines
⬇️
artículo científico publicado el 1 de julio de 1983
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics
artículo científico publicado en 2012
Disk diffusion and disk elution tests with A-56268 and erythromycin.
artículo científico publicado en 1987
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin
⬇️
artículo científico publicado el 1 de marzo de 1992
Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor
artículo científico publicado en 2004
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
artículo científico publicado en 1987
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem
artículo científico publicado en 1988
Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid
artículo científico publicado en 1984
Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
artículo científico publicado en 1986
Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents
⬇️
artículo científico publicado el 1 de diciembre de 1997
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories
artículo científico publicado en 1984
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2005
Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific Nations
artículo científico publicado en 2009
Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio
artículo científico publicado en 2013
Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2003
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations
artículo científico publicado en 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)
artículo científico publicado en 2004
E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates
artículo científico publicado en 1993
Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.
artículo científico publicado en 2010
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY
artículo científico publicado el 1 de enero de 2011
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr
artículo científico publicado en 2013
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.
artículo científico publicado en 2013
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria
scientific article published on 01 September 1987
Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
artículo científico publicado en 2016
Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: Results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012
artículo científico publicado en 2014
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus
artículo científico publicado en 1994
Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries
artículo científico publicado en 2011
Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2008
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
artículo científico publicado en 2006
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program
artículo científico publicado en 2008
Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy).
artículo científico publicado en 2009
Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital
artículo científico publicado en 2003
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)
scientific article published on 20 March 2006
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
artículo científico publicado en 2006
Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: report from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2004
Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan
artículo científico publicado en 2004
Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods
artículo científico publicado en 2002
Emerging epidemic of metallo-beta-lactamase-mediated resistances
artículo científico publicado en 2005
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199
artículo científico publicado en 2001
Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.
artículo científico publicado en 2005
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group
artículo científico publicado en 1995
Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strains.
artículo científico publicado en 1995
Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.
artículo científico publicado en 1999
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
artículo científico publicado en 1993
Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
artículo científico publicado en 2014
Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).
artículo científico publicado en 2001
Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".
artículo científico publicado en 2018
Escherichia coli resistance to quinolones at a comprehensive cancer center
artículo científico publicado en 2010
Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.
artículo científico publicado en 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers
artículo científico publicado en 1994
Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species
⬇️
artículo científico publicado el 1 de diciembre de 2001
Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species
⬇️
artículo científico publicado el 1 de noviembre de 2001
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests
artículo científico publicado en 2005
Evaluation of S1 chromogenic cephalosporin beta-lactamase disk assay tested against gram-positive anaerobes, coagulase-negative staphylococci, Prevotella spp. and Enterococcus spp
artículo científico publicado en 1995
Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006.
artículo científico publicado en 2010
Evaluation of Vitek and API 20S for species identification of enterococci
scientific article published on 01 August 1995
Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria
artículo científico publicado en 1986
Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2005
Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci
artículo científico publicado en 1997
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases,
artículo científico publicado en 2014
Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions
artículo científico publicado en 2006
Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serum
artículo científico publicado en 2008
Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime
artículo científico publicado en 1989
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas
artículo científico publicado en 2000
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.
artículo científico publicado en 1985
Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
artículo científico publicado en 1988
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin
artículo científico publicado en 2002
Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA.
artículo científico publicado en 1994
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
artículo científico publicado en 1999
Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones
artículo científico publicado en 2012
Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media
artículo científico publicado en 2000
Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
artículo científico publicado en 1999
Evaluation of teicoplanin and vancomycin disk susceptibility tests
scientific article published on January 1986
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis
artículo científico publicado en 1994
Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitis
artículo científico publicado en 1995
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media
artículo científico publicado en 2000
Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods
artículo científico publicado en 1982
Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation
artículo científico publicado en 1981
Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study
artículo científico publicado en 1980
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime
artículo científico publicado en 1998
Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada
artículo científico publicado en 2009
Evaluation of the cefonicid disk test criteria, including disk quality control guidelines
artículo científico publicado en 1983
Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).
artículo científico publicado en 2004
Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis
artículo científico publicado en 2000
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin
artículo científico publicado en 1985
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)
scientific article published on 19 January 2007
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories
artículo científico publicado en 2002
Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals. Chinese Antimicrobial Resistance Study Group
artículo científico publicado en 1999
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and β-lactamase producing bacteria
⬇️
artículo científico publicado el 1 de abril de 1995
Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study.
artículo científico publicado en 1980
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
scientific article published on 27 July 2009
Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods
artículo científico publicado en 2013
Evaluations of the Etest for antimicrobial susceptibility testing of Legionella pneumophila, including validation of the imipenem and sparfloxacin strips
scientific article published on 01 November 1994
Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
artículo científico publicado en 2005
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure
artículo científico publicado en 2016
Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program.
artículo científico publicado en 2003
Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia
artículo científico publicado en 2010
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
artículo científico publicado en 2009
Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2012
Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent
artículo científico publicado en 2007
False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae.
artículo científico publicado en 1991
False resistance to metronidazole by E-test among anaerobic bacteria investigations of contributing test conditions and medium quality
scientific article published on 01 February 1996
First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan
artículo científico publicado en 2002
First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2009
First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2004
First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization
artículo científico publicado en 2010
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States
artículo científico publicado en 2008
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program
⬇️
artículo científico publicado el 1 de mayo de 2003
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates
artículo científico publicado en 2010
Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).
artículo científico publicado en 2000
Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)
artículo científico publicado en 1998
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
scientific article published on 01 November 2004
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers
artículo científico publicado en 2002
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata
artículo científico publicado en 2012
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates
artículo científico publicado en 2013
Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011).
artículo científico publicado en 2013
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients
artículo científico publicado en 2008
Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.
artículo científico publicado en 2010
GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria
artículo científico publicado en 2001
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae
artículo científico publicado en 2007
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.
artículo científico publicado en 1999
Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections
artículo científico publicado en 2002
Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae
artículo científico publicado en 2002
Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.
artículo científico publicado en 2003
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.
artículo científico publicado en 2000
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole
artículo científico publicado en 2015
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America
artículo científico publicado en 2004
Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
artículo científico publicado en 1981
Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation
artículo científico publicado en 1981
Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)
⬇️
artículo científico publicado el 10 de noviembre de 2010
Geographic and Temporal Patterns of Antimicrobial Resistance in Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016
artículo científico publicado en 2019
Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997–2000)
⬇️
artículo científico publicado el 1 de mayo de 2003
Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
artículo científico publicado en 2002
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
artículo científico publicado en 2002
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
artículo científico publicado en 2006
Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes
artículo científico publicado en 2007
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001).
artículo científico publicado en 2003
Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)
artículo científico publicado en 1999
Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin
artículo científico publicado en 2002
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center
artículo científico publicado en 2016
Historical overview of the cephalosporin spectrum: Four generations of structural evolution
Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates
⬇️
artículo científico publicado el 1 de junio de 1998
IMP-33, a New IMP variant detected in Pseudomonas aeruginosa from Sicily
artículo científico publicado en 2013
Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States laboratories, 1983-1985
artículo científico publicado en 1986
Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
artículo científico publicado en 1985
Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018)
artículo científico publicado en 2019
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial
artículo científico publicado en 2007
Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001)
artículo científico publicado en 2002
Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia
artículo científico publicado en 2002
Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.
artículo científico publicado en 2005
In Vitro Activity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea and Clostridium difficile
⬇️
artículo científico publicado el 13 de diciembre de 2010
In Vitro Activity of Cefepime and Other Broad-Spectrum β-Lactams Tested Against 129 mec A-negative Staphylococcus spp. Isolates: A Multicenter Sample
⬇️
artículo científico publicado el 1 de enero de 1998
In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014
artículo científico publicado en 2016
In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program
artículo científico publicado en 2015
In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi
⬇️
artículo científico publicado el 1 de abril de 1998
In Vitro Evaluation of HR810, a New Wide-Spectrum Aminothiazolyl α-Methoxyimino Cephalosporin
artículo científico publicado en 1984
In Vitro Evaluation of Sparfloxacin Activity and Spectrum Against 24,940 Pathogens Isolated in the United States and Canada, the Final Analysis
⬇️
artículo científico publicado el 1 de mayo de 1998
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America
artículo científico publicado en 1999
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci
⬇️
artículo científico publicado en 1990
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
artículo científico publicado en 1988
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
artículo científico publicado en 2003
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds
artículo científico publicado en 2013
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans
artículo científico publicado en 2001
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans
artículo científico publicado en 2000
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
artículo científico publicado en 2002
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci
artículo científico publicado en 2004
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
artículo científico publicado en 2003
In vitro activity and disk susceptibility of Timentin: current status
artículo científico publicado en 1985
In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.
artículo científico publicado en 1997
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.
artículo científico publicado en 1991
In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum
artículo científico publicado en 2002
In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
artículo científico publicado en 1991
In vitro activity of CP-74667 compared with four other fluoroquinolones
scientific article published on 01 August 1992
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents.
artículo científico publicado en 1986
In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone
artículo científico publicado en 1993
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.
artículo científico publicado en 1993
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101
artículo científico publicado en 1988
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester
artículo científico publicado en 1991
In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
artículo científico publicado en 2015
In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates
artículo científico publicado en 1989
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin
artículo científico publicado en 1987
In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods
artículo científico publicado en 2012
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi
⬇️
artículo científico publicado el 1 de enero de 1998
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods
artículo científico publicado en 2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method
artículo científico publicado en 2011
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers
artículo científico publicado en 1984
In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii
artículo científico publicado en 2005
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates
artículo científico publicado en 1986
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: A multicenter sample
⬇️
artículo científico publicado el 1 de diciembre de 1997
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers
artículo científico publicado en 1993
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
artículo científico
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
artículo científico publicado en 2009
In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011).
artículo científico publicado en 2014
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients
artículo científico publicado en 2016
In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum beta-lactamase producing strains
artículo científico publicado en 2000
In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species
artículo científico publicado en 1990
In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
artículo científico publicado en 2016
In vitro activity of fidaxomicin (OPT-80) tested against contemporary clinical isolates of Staphylococcus spp. and Enterococcus spp
artículo científico publicado en 2010
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
artículo científico publicado en 2007
In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methods
artículo científico publicado en 1999
In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects
artículo científico publicado en 2009
In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis
scientific article published on 01 June 1995
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program
artículo científico publicado en 2014
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
artículo científico publicado en 1980
In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2000
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus
artículo científico publicado en 2008
In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested species
scientific article published on 01 July 1996
In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998
artículo científico publicado en 2000
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates
artículo científico publicado en 2010
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
artículo científico publicado en 1986
In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide
artículo científico publicado en 1993
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates
artículo científico publicado en 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers
⬇️
artículo científico publicado el 1 de junio de 1984
In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections
artículo científico publicado en 2004
In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America
artículo científico publicado en 2005
In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
artículo científico publicado en 1990
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
artículo científico publicado en 2015
In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): A novel orally administered streptogramin combination
⬇️
artículo científico publicado el 1 de julio de 1997
In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin
artículo científico publicado en 1981
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones.
artículo científico publicado en 1993
In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases
artículo científico publicado en 2001
In vitro antimicrobial activity of RU-59863, A C-7 catechol substituted cephalosporin
⬇️
artículo científico publicado el 1 de junio de 1997
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
artículo científico publicado en 2015
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies
artículo científico publicado en 1985
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds
artículo científico publicado en 1991
In vitro antimicrobial activity of tigemonam, a new orally administered monobactam
artículo científico publicado en 1988
In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application.
artículo científico publicado en 1993
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States
artículo científico publicado en 2011
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
artículo científico publicado en 1987
In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disks.
artículo científico publicado en 1985
In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (19
artículo científico publicado en 2002
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers
artículo científico publicado en 1985
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers
artículo científico publicado en 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers
scientific article published on 01 November 1993
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates
artículo científico publicado en 1991
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains
scientific article published on 01 December 1996
In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
artículo científico publicado en 2000
In vitro evaluation of A-56619 and A-56620, two new quinolones
artículo científico publicado en 1986
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci
artículo científico publicado en 2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species
artículo científico publicado en 2002
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates
artículo científico publicado en 2002
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits
artículo científico publicado en 1983
In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci
artículo científico publicado en 2002
In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent
artículo científico publicado en 2001
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.
artículo científico publicado en 1982
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes
artículo científico publicado en 1995
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin
artículo científico publicado en 1984
In vitro evaluation of LY127935 (6059S) compared with cefotaxime, eight other β-lactams and two aminoglycosides
⬇️
artículo científico publicado el 1 de noviembre de 1980
In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone
artículo científico publicado en 1990
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
artículo científico publicado en 1997
In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae
⬇️
artículo científico publicado el 1 de agosto de 1998
In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of broad-spectrum beta-lactams tested in medical centers in Korea: role of fourth-generation cephalosporins. The Korean Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group
artículo científico publicado en 1999
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria
artículo científico publicado en 1986
In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci
scientific article published on 01 April 1997
In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds
scientific article published on April 1982
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
artículo científico publicado en 1989
In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs
artículo científico publicado en 1983
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition
artículo científico publicado en 1987
In vitro interaction between the penem FCE 22101 and ceftazidime.
artículo científico publicado en 1988
In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation
artículo científico publicado en 2008
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens
artículo científico publicado en 2009
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms
artículo científico publicado en 2015
In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agents
artículo científico publicado en 2016
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole
artículo científico publicado en 1998
In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States
scientific article published on 01 July 1993
In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry
⬇️
artículo científico publicado el 1 de septiembre de 1998
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp
artículo científico publicado en 1998
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
artículo científico publicado en 1989
In-vitro activity of FK-037, a new parenteral cephalosporin
artículo científico publicado en 1994
In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli
artículo científico publicado en 1992
In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study
artículo científico publicado en 1994
In-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin.
artículo científico publicado en 1998
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests
scientific article published on 01 March 1989
In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates
scientific article published on 01 April 1996
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates
artículo científico publicado en 1993
In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
artículo científico publicado en 1985
In-vitro studies of meropenem
scientific article published on 01 September 1989
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
artículo científico publicado en 1986
In71, an Enterobacter cloacae blaVIM-1 -Carrying Integron Related to In70.2 from Italian Pseudomonas aeruginosa Isolates: A SENTRY Antimicrobial Surveillance Program Report
article
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates
scientific article published on 01 April 2008
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
artículo científico publicado en 2006
Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)
scientific article published on 29 May 2003
Inducible amp C β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)
⬇️
artículo científico publicado el 1 de agosto de 1997
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo
artículo científico publicado en 1987
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis
artículo científico publicado en 1984
Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North
artículo científico publicado en 2006
Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program
⬇️
artículo científico publicado el 1 de mayo de 2003
Influence of polysorbate-80 when determining the tigecycline MIC by the reference method
scientific article published on 26 March 2007
Initial broth microdilution quality control guidelines for Debio 1452, a FabI inhibitor antimicrobial agent
artículo científico publicado en 2015
Initial disk diffusion quality control guidelines for tylosin tested against Staphylococcus aureus ATCC 25923 and Streptococcus pneumoniae ATCC 49619
scientific article published on 01 June 2003
Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity
artículo científico publicado en 2003
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
artículo científico publicado en 2004
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program
artículo científico publicado en 2001
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.
scientific article published on December 2004
Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species
artículo científico publicado en 2012
Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials
artículo científico publicado en 1993
International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program
⬇️
artículo científico publicado el 1 de julio de 1998
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).
artículo científico publicado en 2006
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group
scientific article published on 01 September 1999
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia
artículo científico publicado en 2001
Interpretative criteria for the agar diffusion susceptibility test with azithromycin.
artículo científico publicado en 1988
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.
artículo científico publicado en 1993
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent
artículo científico publicado en 2008
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan
artículo científico publicado en 1991
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group
artículo científico publicado en 1990
Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
artículo científico publicado en 1984
Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disks
artículo científico publicado en 1994
Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae
artículo científico publicado en 1993
Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic
scientific article published on March 1990
Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates
scientific article published on April 1992
Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae
scientific article published on 01 June 1994
Interpretive criteria for temocillin disk diffusion susceptibility testing.
artículo científico publicado en 1985
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.
artículo científico publicado en 1990
Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
artículo científico publicado en 1995
Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests
artículo científico publicado en 1985
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks
artículo científico publicado en 1984
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks
⬇️
artículo científico publicado el 1 de febrero de 1984
Interpretive standards of cefbuperazone disk diffusion susceptibility tests
Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values
artículo científico publicado en 2014
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints an
artículo científico publicado en 2015
Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.
artículo científico publicado en 2004
JNJ-Q2, a New Fluoroquinolone with Potent In Vitro Activity against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains
⬇️
artículo científico publicado el 9 de mayo de 2011
Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4.
artículo científico publicado en 2016
Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods
artículo científico publicado en 2013
LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States
⬇️
artículo científico publicado el 13 de junio de 2011
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)
artículo científico publicado en 2007
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
artículo científico publicado en 2012
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks
artículo científico publicado en 1986
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
artículo científico publicado en 2016
Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2003
Linezolid surveillance program results for 2008 (LEADER Program for 2008).
artículo científico publicado en 2009
Linezolid surveillance results for the United States: LEADER surveillance program 2011.
artículo científico publicado en 2012
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
artículo científico publicado en 2014
Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2002
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency
artículo científico publicado en 2016
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains
artículo científico publicado en 2010
MIC quality control guidelines and disk diffusion test optimization for CEM-101, a novel fluoroketolide
artículo científico publicado en 2009
MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methods
artículo científico publicado en 2004
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections
artículo científico publicado en 2000
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)
artículo científico publicado en 2000
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).
artículo científico publicado en 2000
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011.
artículo científico publicado en 2012
Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America
artículo científico publicado en 2015
Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins
artículo científico publicado en 1983
Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico
artículo científico publicado en 2007
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico
artículo científico publicado en 2008
Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission
artículo científico publicado en 1999
Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.
artículo científico publicado en 1991
Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing
artículo científico publicado en 1981
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections
artículo científico publicado en 2006
Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination
artículo científico publicado en 2015
Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2006
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Con
artículo científico publicado en 1994
Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).
artículo científico publicado en 2016
Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
artículo científico publicado en 1984
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.
artículo científico publicado en 1995
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.
artículo científico publicado en 2003
Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme
artículo científico publicado en 2002
Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections
artículo científico publicado en 2007
Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.
scientific article published on December 2004
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China
⬇️
artículo científico publicado el 23 de octubre de 2012
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil
artículo científico publicado en 1993
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan
artículo científico publicado en 2002
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci
artículo científico publicado en 2003
Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2004
Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil
artículo científico publicado en 2002
More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA
⬇️
artículo científico publicado el 13 de marzo de 2013
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
artículo científico publicado en 1980
Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolates
artículo científico publicado en 1996
Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States
artículo científico publicado en 2001
Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226.
artículo científico publicado en 2016
Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
artículo científico publicado en 2002
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime
artículo científico publicado en 1993
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group
artículo científico publicado en 1997
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group
artículo científico publicado en 1999
Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates
artículo científico
Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group
artículo científico publicado en 1999
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group
artículo científico publicado en 1998
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group
artículo científico publicado en 1999
Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
artículo científico publicado en 2009
Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group
artículo científico publicado en 1998
Multicenter in vitro evaluation of SM-7338, a new carbapenem
artículo científico publicado en 1989
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
artículo científico publicado en 1988
Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa
⬇️
artículo científico publicado el 1 de agosto de 1997
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
artículo científico publicado en 2006
Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).
artículo científico publicado en 2002
Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific
artículo científico publicado en 2003
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria
artículo científico publicado en 1993
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals
artículo científico publicado en 2014
National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program
⬇️
artículo científico publicado el 1 de mayo de 1998
Neisseria meningitidis with decreased susceptibility to penicillin: Report from the SENTRY antimicrobial surveillance program, North America, 1998–99
⬇️
artículo científico publicado el 1 de septiembre de 2001
Netilmicin disk susceptibility tests: effect of cations on the MIC correlates
artículo científico publicado en 1987
Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates
artículo científico publicado en 1993
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus
artículo científico publicado en 2009
Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012.
artículo científico publicado en 2015
Norfloxacin (MK-0366, AM-715): In vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing
⬇️
artículo científico publicado el 1 de junio de 1983
North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.
artículo científico publicado en 1994
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility
artículo científico publicado en 2000
Nosocomial bloodstream infections in United States hospitals: a three-year analysis
artículo científico publicado en 1999
Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy
⬇️
artículo científico publicado el 1 de octubre de 1997
Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis
scientific article published on 01 June 1994
OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins
artículo científico publicado en 2011
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
artículo científico publicado en 2004
Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)
⬇️
artículo científico publicado el 1 de abril de 2003
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
artículo científico publicado en 2006
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
artículo científico publicado en 2010
Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
artículo científico publicado en 2006
Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America
artículo científico publicado en 2000
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals
artículo científico publicado en 2009
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
scientific article published on January 1989
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group
artículo científico publicado en 1992
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients
scientific article published on 13 March 2020
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity
artículo científico publicado en 2004
Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions
artículo científico publicado en 1988
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination
artículo científico publicado en 1987
Oral beta-lactams applied to uncomplicated infections of skin and skin structures
artículo científico publicado en 2007
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results
artículo científico publicado en 2016
Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
⬇️
artículo científico publicado el 1 de abril de 2012
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program
artículo científico publicado en 2014
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010
artículo científico publicado en 2011
Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013-2014).
artículo científico publicado en 2016
Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker
artículo científico publicado en 1993
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2006
Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study.
artículo científico publicado en 1993
Oxazolidinone antibiotics.
artículo científico publicado en 2001
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study
artículo científico publicado en 2007
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations
artículo científico publicado en 2005
Oxazolidinones: a review
artículo científico publicado en 2000
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program
⬇️
artículo científico publicado el 7 de marzo de 2003
Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.
artículo científico publicado en 2002
Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)
⬇️
artículo científico publicado el 1 de abril de 2003
Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003).
artículo científico publicado en 2006
Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants
artículo científico publicado en 2015
Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus
artículo científico publicado en 2010
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime
artículo científico publicado en 2002
Pharmacodynamics in the evaluation of drug regimens
artículo científico publicado en 2002
Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model
artículo científico publicado en 2006
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation
artículo científico publicado en 2007
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases
artículo científico publicado en 2011
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
artículo científico publicado en 2008
Pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis
artículo científico publicado en 2017
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
artículo científico publicado en 2016
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model
artículo científico publicado en 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane
artículo científico publicado en 2013
Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases
artículo científico publicado en 1999
Phenotypic detection of mec A-positive staphylococcal blood stream isolates: high accuracy of simple disk diffusion tests
artículo científico publicado en 1996
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin
artículo científico publicado en 1979
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin
artículo científico publicado el 1 de diciembre de 1977
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains
scientific article published on 01 November 1989
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States
artículo científico publicado en 2011
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)
scientific article published on 27 January 2020
Polymyxins: wisdom does not always come with age.
artículo científico
Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strains
artículo científico publicado en 2014
Postantibiotic effects of E-4868 and OPC-17116.
artículo científico publicado en 1993
Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!
artículo científico publicado en 2000
Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections
artículo científico publicado en 2002
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates
artículo científico publicado en 2009
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli
artículo científico publicado en 2013
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
artículo científico publicado en 2007
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
artículo científico publicado en 2005
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates
artículo científico publicado en 2004
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
artículo científico publicado en 2005
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).
artículo científico publicado en 2010
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa
artículo científico publicado en 2007
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates
artículo científico publicado en 2004
Practical approach to the identification of clinically relevant Enterococcus species
article
Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods
artículo científico publicado en 2011
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests
artículo científico publicado en 1987
Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents
⬇️
artículo científico publicado el 1 de diciembre de 1995
Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone
artículo científico publicado en 2004
Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens
artículo científico publicado en 1996
Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENT
artículo científico publicado en 2006
Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific S
artículo científico publicado en 2007
Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
⬇️
artículo científico publicado el 1 de octubre de 1998
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)
artículo científico publicado en 2000
Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).
artículo científico publicado en 2002
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.
artículo científico publicado en 2003
Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.
artículo científico publicado en 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobact
scientific article published on 01 December 1994
Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents
artículo científico publicado en 2016
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
artículo científico publicado en 2013
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxac
artículo científico publicado en 1996
Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests
artículo científico publicado en 1988
Proposed disk diffusion susceptibility criteria for ofloxacin.
artículo científico publicado en 1985
Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin
artículo científico publicado en 2001
Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values
artículo científico publicado en 2008
Proposed zone standards for interpretation of fortimicin A disk diffusion tests
artículo científico publicado en 1983
Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001).
artículo científico publicado en 2004
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA
scientific article published on 01 March 1994
Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi
⬇️
artículo científico publicado el 4 de mayo de 2011
Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method
artículo científico publicado en 2014
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used
artículo científico publicado en 2004
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.
artículo científico publicado en 1991
Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor
artículo científico publicado en 2003
Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide
artículo científico publicado en 2004
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Cli
scientific article published on 01 February 1996
Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
artículo científico publicado en 2000
Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods
artículo científico publicado en 2005
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria
artículo científico publicado en 1989
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods
artículo científico publicado en 2005
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.
artículo científico publicado en 1981
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
scientific article published on 01 May 1987
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria
artículo científico publicado en 1987
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards
artículo científico publicado en 1989
Quality control of moxalactam susceptibility disks
⬇️
artículo científico publicado el 1 de junio de 1983
Quality control of susceptibility tests with 5-micrograms trimethoprim disks
artículo científico publicado en 1984
Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks.
artículo científico publicado en 1983
Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .
artículo científico publicado en 2014
Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2003
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria
artículo científico publicado en 1987
Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).
artículo científico publicado en 2008
Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages
artículo científico publicado en 2013
Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance
artículo científico publicado en 2009
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae
artículo científico publicado en 2003
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles
artículo científico publicado en 2007
Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid
artículo científico publicado en 1989
Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae
artículo científico publicado en 2007
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases
artículo científico publicado en 2005
Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks
artículo científico publicado en 1996
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms
artículo científico publicado en 2005
Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates.
artículo científico publicado en 1995
Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.
artículo científico publicado en 2014
Regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!
artículo científico publicado en 2014
Regional resistance surveillance program results for 12 Asia-Pacific nations (2011).
artículo científico publicado en 2013
Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
artículo científico publicado en 2005
Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis
scientific article published on 01 October 1995
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model
artículo científico publicado en 2013
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model
artículo científico publicado en 2014
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study
artículo científico publicado en 2017
Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States
artículo científico publicado en 2005
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens
artículo científico publicado en 2003
Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
artículo científico publicado en 1985
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillins
artículo científico publicado en 1987
Reply to Nation et al.
artículo científico publicado en 2013
Reply: regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!
artículo científico publicado en 2014
Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panels
artículo científico publicado en 2005
Reproducibility of dalbavancin MIC test results and an updated surrogate accuracy analysis of vancomycin MIC values to infer dalbavancin susceptibility (2014)
artículo científico publicado en 2016
Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content
artículo científico publicado en 2005
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels
artículo científico publicado en 2005
Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.
artículo científico publicado en 1995
Resistance surveillance program report for selected European nations (2011).
artículo científico publicado en 2013
Resistance to beta-lactams among blood isolates of Salmonella spp. in European hospitals: results from the SENTRY Antimicrobial Surveillance Program 1997-98.
artículo científico publicado en 2003
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2004
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).
artículo científico publicado en 2002
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
artículo científico publicado en 2000
Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility.
artículo científico publicado en 2016
Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres
artículo científico publicado en 2004
Results from the Solithromycin International Surveillance Program (2014).
artículo científico publicado en 2016
Retrospective molecular analysis of DIM-1 metallo-β-lactamase discovered in Pseudomonas stutzeri from India in 2000.
artículo científico publicado en 2013
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium
artículo científico publicado en 1994
Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies
artículo científico publicado en 2014
Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial
⬇️
artículo científico publicado el 1 de octubre de 2003
RmtD 16S RNA methylase in epidemiologically unrelated spm-1-producing Pseudomonas aeruginosa isolates from Brazil
artículo científico publicado en 2008
Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis
artículo científico publicado en 1979
Roxithromycin in-vitro susceptibility testing of Haemophilus influenzae by NCCLS methods. National Committee for Clinical Laboratory Standards
artículo científico publicado en 1993
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.
artículo científico publicado en 2004
Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
artículo científico publicado en 2003
Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000).
artículo científico publicado en 2002
Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition
artículo científico publicado en 1982
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program
artículo científico publicado en 2006
Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem
artículo científico publicado en 2007
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis
artículo científico publicado en 2007
Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): case reports from the SENTRY antimicrobial surveillance program
artículo científico publicado en 2000
Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine
artículo científico publicado en 2014
Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine
artículo científico publicado en 2008
Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease
artículo científico publicado en 2014
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme
artículo científico publicado en 2012
Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns
artículo científico publicado en 2002
Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991
scientific article published on 01 February 1993
Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): More alike than different!
⬇️
artículo científico publicado el 1 de noviembre de 2001
Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal health.
artículo científico publicado en 1999
Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.
artículo científico publicado en 2002
Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010.
artículo científico publicado en 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
artículo científico publicado en 2012
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
artículo científico publicado en 2013
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
artículo científico publicado en 2006
Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
artículo científico publicado en 2010
Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program
⬇️
artículo científico publicado el 1 de diciembre de 2010
Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilm
artículo científico publicado el 1 de diciembre de 2001
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline
artículo científico publicado en 1989
Staphylococcus aureus and Coagulase-Negative Staphylococci from Blood Stream Infections: Frequency of Occurrence, Antimicrobial Susceptibility, and Molecular (mecA) Characterization of Oxacillin Resistance in the SCOPE Program
⬇️
artículo científico publicado el 1 de marzo de 1998
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group
artículo científico publicado en 1989
Stomatococcus mucilaginosus bacteremias. Typical case presentations, simplified diagnostic criteria, and a literature review
artículo científico publicado en 1990
Strategic Design of an Effective -Lactamase Inhibitor: LN-1-255, A 6-ALKYLIDENE-2'-SUBSTITUTED PENICILLIN SULFONE
artículo científico publicado en 2009
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents
artículo científico publicado en 2013
Studies to establish quality control ranges for SB-265805 (LB2030) when using National Committee for Laboratory Standards antimicrobial susceptibility test methods. Quality Control Study Group
artículo científico publicado en 1999
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
artículo científico publicado en 1989
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program
artículo científico publicado en 2012
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States
artículo científico publicado en 2013
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).
artículo científico publicado en 2009
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin
artículo científico publicado en 2015
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates
artículo científico publicado en 2016
Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae
artículo científico publicado en 2004
Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 sentry antimicrobial surveillance program
⬇️
artículo científico publicado el 5 de octubre de 2011
Surveillance of dalbavancin potency and spectrum in the United States (2012).
artículo científico publicado en 2013
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance
scientific article published on 01 April 1999
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
artículo científico publicado en 1999
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve
artículo científico publicado en 2001
Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006–2009)
⬇️
artículo científico publicado el 30 de noviembre de 2010
Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones
artículo científico publicado en 1988
Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemo
artículo científico publicado en 2005
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents
artículo científico publicado en 2005
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Prog
⬇️
artículo científico publicado el 1 de abril de 2003
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011).
artículo científico publicado en 2013
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams
artículo científico publicado en 2005
Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
artículo científico publicado en 1992
Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis
artículo científico
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods
artículo científico publicado en 1987
Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin
artículo científico publicado en 2006
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2003
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000).
artículo científico publicado en 2003
Sustained antimicrobial activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from United States Medical Centers from 2004 through 2008.
artículo científico publicado en 2010
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
artículo científico publicado en 2009
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections
artículo científico publicado en 2010
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia
⬇️
artículo científico publicado el 16 de septiembre de 2010
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin
artículo científico publicado en 2015
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014).
artículo científico publicado en 2016
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007–2009)
⬇️
artículo científico publicado el 10 de noviembre de 2011
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013).
artículo científico publicado en 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States
artículo científico publicado en 2015
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests
artículo científico publicado en 1989
Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains
artículo científico publicado en 1984
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
artículo científico publicado en 1986
Tentative disk diffusion susceptibility interpretive criteria for pefloxacin
artículo científico publicado en 1986
Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone
⬇️
artículo científico publicado el 1 de mayo de 1982
The Genetic Environment of the cfr Gene and the Presence of Other Mechanisms Account for the Very High Linezolid Resistance of Staphylococcus epidermidis Isolate 426-3147L
⬇️
artículo científico publicado el 17 de diciembre de 2012
The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance Program
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
artículo científico publicado en 2019
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2019
The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance
artículo científico publicado en 1993
The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
artículo científico publicado en 1984
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin
scientific article published on 01 September 2006
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam
artículo científico publicado en 1986
The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method
scientific article published on 01 June 1987
The antimicrobial activity of cephalexin against old and new pathogens
artículo científico publicado el 1 de enero de 1983
The application of in vitro surveillance data for antibacterial dose selection
artículo científico publicado en 2017
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
artículo científico publicado en 1985
The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci
scientific article published on 01 May 1996
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
artículo científico publicado en 1993
The in vitro activity of sulphones alone and in combination with ampicillin or amoxicillin against Legionella pneumophila and other Legionella spp. including beta-lactamase studies
artículo científico publicado en 1985
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
⬇️
artículo científico publicado el 8 de septiembre de 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008).
artículo científico publicado en 2010
The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
artículo científico publicado en 1989
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae
artículo científico publicado en 2005
Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates
scientific article published on 01 February 2001
Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods
artículo científico publicado en 2002
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates
artículo científico publicado el 1 de noviembre de 1977
Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci
artículo científico publicado en 2006
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents
artículo científico publicado en 2005
Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
artículo científico publicado en 2013
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
artículo científico publicado en 2015
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).
artículo científico publicado en 2011
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).
artículo científico publicado en 2016
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view
artículo científico publicado en 2007
Timed Kill Kinetic Studies of Levofloxacin, Ofloxacin, and Ciprofloxacin Against Moraxella catarrhalis
⬇️
artículo científico publicado el 1 de febrero de 1998
Treatment of Methicillin-Susceptible Staphylococcus aureus Osteoarticular and Prosthetic Joint Infections: Using the Oxacillin Minimum Inhibitory Concentration to Guide Appropriate Ceftriaxone Use
⬇️
artículo científico publicado el 28 de marzo de 2013
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program
artículo científico publicado en 2013
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
artículo científico publicado en 2002
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group
artículo científico publicado en 2000
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
artículo científico publicado en 2011
Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital
artículo científico publicado en 1993
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program
artículo científico publicado en 2005
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program
artículo científico publicado en 2005
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States
artículo científico publicado en 1999
Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida
artículo científico publicado en 2011
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Species From 1997-2016
Twenty-Year Trends in Antimicrobial Susceptibilities Among From the SENTRY Antimicrobial Surveillance Program
Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species
scientific article published on 01 January 1996
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTR
artículo científico publicado en 2000
Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America
artículo científico publicado en 2003
United States resistance surveillance results for linezolid (LEADER Program for 2007).
artículo científico publicado en 2008
Unmet Needs and Prospects for Oritavancin in the Management of Vancomycin-Resistant Enterococcal Infections
⬇️
artículo científico publicado el 1 de abril de 2012
Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides
artículo científico publicado en 1987
Unpredictable interactions between cefotetan and penicillins or aminoglycosides
scientific article published on 01 September 1984
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations
artículo científico publicado en 2009
Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011).
artículo científico publicado en 2013
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).
artículo científico publicado en 2013
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group
artículo científico publicado en 1994
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
artículo científico publicado en 2008
Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
artículo científico publicado en 2008
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
artículo científico publicado en 2014
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options
artículo científico publicado en 2014
Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
artículo científico publicado en 2012
Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011-13)
artículo científico publicado en 2015
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis
artículo científico publicado en 2010
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.
artículo científico publicado en 2015
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
artículo científico publicado en 2006
Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007).
artículo científico publicado en 2009
Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010.
artículo científico publicado en 2012
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).
artículo científico publicado en 2011
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
artículo científico publicado en 2002
Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci
⬇️
artículo científico publicado el 1 de octubre de 1998
Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patients.
artículo científico publicado en 1995
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin
⬇️
artículo científico publicado el 25 de octubre de 2012
Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria
artículo científico publicado en 2014
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections
artículo científico publicado en 2007
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide.
artículo científico publicado en 2015
Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria
artículo científico publicado en 2013
Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis
artículo científico publicado en 2004
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis
artículo científico publicado en 2008
Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.
artículo científico publicado en 1997
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards
artículo científico publicado en 1994
Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor Combination
artículo científico publicado en 2015
Validation of a commercial dry-form broth microdilution device (Sensititre) for testing tedizolid, a new oxazolidinone
artículo científico publicado en 2014
Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).
artículo científico publicado en 2001
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide
artículo científico publicado en 2004
Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone
artículo científico publicado en 2003
Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program
⬇️
artículo científico publicado el 1 de septiembre de 1997
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test
artículo científico publicado en 1988
Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)
⬇️
artículo científico publicado el 16 de septiembre de 2010
Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012).
artículo científico publicado en 2014
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
article
Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles
artículo científico publicado en 1996
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.
artículo científico publicado en 2017
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
artículo científico publicado en 2017
WITHDRAWN: Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem
artículo científico publicado en 2007
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method
artículo científico publicado en 2011
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
artículo científico publicado en 2012
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
artículo científico publicado en 2009
Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team
artículo científico publicado en 2003
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents
artículo científico publicado en 2012
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates
artículo científico publicado en 2004
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
artículo científico publicado en 2001
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
artículo científico publicado en 2010
ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries
artículo científico publicado en 2009
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries
artículo científico publicado en 2012
Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains
artículo científico publicado en 2008
Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries
artículo científico publicado en 2007
Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
artículo científico publicado en 2009
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
artículo científico publicado en 2014
[Cephalosporins: 4 generations of structural evolution]
artículo científico publicado en 1995
[Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria].
artículo científico publicado en 1997
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]
artículo científico publicado en 1996
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.
artículo científico publicado en 2006
blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States
artículo científico publicado en 2004
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
artículo científico publicado en 2015